The Biden administration is paying Ellume Health $231.8m to build a factory in the US to boost production of their rapid COVID-19 at-home diagnostic test. Until the factory is built, the US will receive half the tests manufactured by the company in Australia.
In a joint press release from the Department of Defense and the Department of Health and Human Services, the US government announced on 1 February it has given the Australian...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?